Page last updated: 2024-10-26

ellipticine and Lung Injury, Acute

ellipticine has been researched along with Lung Injury, Acute in 1 studies

ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.

Research Excerpts

ExcerptRelevanceReference
"Ellipticine treatment dramatically reduced inflammatory cells infiltration, MPO activity, serum amylase and lipase activity and the protein concentration of BALF."5.56Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury. ( Li, X; Mulati, M; Qian, F; Sun, L; Ye, C, 2020)
"Ellipticine treatment dramatically reduced inflammatory cells infiltration, MPO activity, serum amylase and lipase activity and the protein concentration of BALF."1.56Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury. ( Li, X; Mulati, M; Qian, F; Sun, L; Ye, C, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Li, X1
Ye, C1
Mulati, M1
Sun, L1
Qian, F1

Other Studies

1 other study available for ellipticine and Lung Injury, Acute

ArticleYear
Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury.
    Biochemical pharmacology, 2020, Volume: 177

    Topics: Acute Lung Injury; Adaptor Proteins, Signal Transducing; Amylases; Animals; Anti-Inflammatory Agents

2020